Global Agenda: Why are bonds falling?

There is a simple way to explain both rising share prices and falling bond prices. It’s called economic recovery.

By PINCHAS LANDAU
August 1, 2013 23:28
4 minute read.
Israeli gold bullion coins

Israel gold bullion coins money wealth economy 370. (photo credit: Eli Gross/Keren Or)

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user uxperience almost completely free of ads
  • Access to our Premium Section and our monthly magazine to learn Hebrew, Ivrit
  • Content from the award-winning Jerusalem Repor
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

The outstanding features of the financial markets in recent weeks, especially in the US, have been that share prices are rising and bond prices are falling. Each of these phenomena on its own is subject to the usual debate as to what is causing it. But finding an explanation that fits both at the same time is more difficult.

Most analysts – including the mainstream ones working for big banks and investment houses, but especially the ones who think and work outside the consensus – believe that the key factor behind the ongoing rise in shares is the unprecedented liquidity being injected into the financial system by the central banks, including the Fed, the ECB and the Bank of Japan.

Be the first to know - Join our Facebook page.


There is even agreement that corporate “fundamentals,” meaning the level of earnings and expectations of future earnings, are not good enough to justify the ongoing uptrend – and, indeed, the most recent set of earnings has been generally disappointing. The macro-economic picture is weak or, in the best interpretation, not strong.

But in that case, and given how low inflation rates are, bonds should still be in demand and their prices should be rising while their yields fall. Yet, for the last year, bond yields have been rising. To make matters worse, from an analytical point of view, government bond yields have risen sharply, despite the fact that the Fed is engaged in buying no less than $85 billion every month of US Treasuries and mortgage debt issued by government agencies. This alone should have put a floor under bond prices and ensured that they would not fall.

Yet fall they have. The yield on 10-year US government bonds is currently around 2.7 percent, almost double the record-low level of 1.39% reached last summer. Thirty-year bond yields have risen even more and are now at 3.7%, which has fed through into a sharp rise in mortgage lending rates.

That, in turn, has sent the demand for new mortgages plunging, and crushed the “refi” market in which borrowers refinance their existing mortgage by taking out a new loan at a lower interest rate. These developments threaten to undermine the recovery in the housing market, which is a key component of the overall economic recovery that the Fed’s aggressive monetary policy is aimed at spurring.

However, there is a simple way to explain both rising share prices and falling bond prices. It’s called economic recovery.



When an economy recovers from a recession, especially a deep and prolonged one, there is a stage in which the equity market does well – because the nascent recovery implies rising profits in the future, while bond prices fall because the recovery is expected to translate into stronger demand for loans – meaning higher interest rates – and cause higher inflation, which is bad for fixed income securities, a.k.a. bonds.

In other words, if you believe that the US economy is recovering and that growth is going to improve, so that loan demand rises and inflation too, then it all makes sense. Better still, the outlook is rosy and – at last – all will be well. The economic data released Wednesday – or at least some of it – supports that view.

But not everyone is willing to buy into that happy tale.

First of all, the recovery has supposedly been underway for four years, during most of that time bond prices fell. Secondly, as soon as the Fed hints that it may reduce its bond purchases, all the financial markets tank – suggesting that without the artificial support they are receiving from the Fed, they have no strength, and refuting the idea that they are responding to a recovery in the real economy. Furthermore, if rising interest rates threaten to choke off whatever recovery there is, then there can’t have been very much to start with.

There is a more ominous explanation of the phenomenon of rising interest rates. It says that rates are not rising because of an incipient recovery, but because lenders are getting increasingly worried about the ability of borrowers to pay.

The underlying financial condition of cities and states in the US and of countries in Europe is, in a word, terrible. Detroit, as discussed here last week, is likely to be the first of many major cities to admit it cannot pays its debts, let alone meet the promises it extended to its employees for pensions and healthcare. This approach doesn’t attempt to reconcile the boom in the equity market – dismissed as “la-la-land” – with the decline in bond prices, seen as “reality.”

It is greatly to be hoped that this is a mistaken view, but hope is not a sensible basis for making decisions.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS